PulseAugur
EN
LIVE 15:06:58
中文(ZH) 我国首部海洋生物医药产业发展的政策文件发布

China issues first policy for marine biopharma industry

China has released its first national policy document aimed at advancing the marine biopharmaceutical industry. The guidance emphasizes integrating resource, technology, industry, and application chains to foster innovation. The goal is to have multiple marine innovative drugs on the market by 2030, with the industry's added value exceeding 130 billion yuan. AI

IMPACT This policy aims to boost innovation in marine pharmaceuticals, potentially leading to new drug discoveries and economic growth in a specialized sector.

RANK_REASON First national policy document for a specific industry. [lever_c_demoted from significant: ic=1 ai=0.1]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

China issues first policy for marine biopharma industry

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
First national policy document for a specific industry. [lever_c_demoted from significant: ic=1 ai=0.1]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
policy, product
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
105 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    China's First Policy Document on the Development of the Marine Biomedical Industry Released

    自然资源部等8部门5月28日发布《关于加快海洋药物和功能制品高质量发展的指导意见》,这是全国层面首部海洋生物医药产业发展的政策文件。指导意见强调统筹加强产业“资源链+科技链+产业链+应用链”全链条创新体系建设,推动科技创新和产业创新深度融合,到2030年实现多项海洋创新药上市,产业增加值突破1300亿元。(新华社)